Investigators assessed whether anticoagulation and platelet aggregation inhibition could have antitumoral effects when used along side targeted therapies for patients with unresectable stage III-IV ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Early initiation of prophylactic anticoagulation in COVID-19 patients newly admitted to hospital ...

Over the past 40 years, major changes have occurred in the area of anticoagulation management. New strategies have been developed for older anticoagulants, older beliefs have been challenged, new ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients hospitalized with COVID-19 who received ...

Therapeutic-dose anticoagulation with heparins reduced 28-day mortality compared with prophylactic doses in patients hospitalized with COVID-19. Higher-dose anticoagulation was associated with a ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation with a stent planted at least 1 year prior, oral anticoagulation ...

Background: Patients taking oral anticoagulant therapy balance the risks of hemorrhage and thromboembolism. We sought to determine the association between anticoagulation intensity and the risk of ...

For patients younger than 21 who have provoked venous thromboembolism (VTE), shortening the length of anticoagulation to prevent a recurrent event is no worse than using it for the standard 3 months, ...

Patients at high risk for thromboembolism who undergo aortic valve replacement with a mechanical valve can safely take less than the standard dose of warfarin after 3 months, according to results of ...

Our extensive research on the United States Anticoagulation Therapy (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, inv ...

Whether or not to recommend anticoagulation for patients with chronic heart failure (HF) is a complex decision. There are scant data concerning the incidence of and risk factors for thromboembolism, ...